Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page
- Check2 days agoChange DetectedBoth screenshots present the same study record with no changes to core content, outcomes, or eligibility. Any differences appear to be cosmetic layout or loading artifact rather than substantive edits. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check31 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference4%

- Check38 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check52 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as a new version revision (v3.0.0). However, many specific medical topics and related resources have been removed.SummaryDifference3%

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.